by David Ernesto Munar, via HuffPo
Lives will be saved when the Food and Drug Administration puts its stamp of approval on a groundbreaking preventative approach called pre-exposure prophylaxis, or PrEP, recently found to reduce HIV infections.
With PrEP, people who are not infected with HIV take a daily pill, usually used to treat the disease, to help prevent infection -- as part of a broad HIV
prevention approach that includes condoms and safer-sex counseling.
But the longer the FDA waits before beginning its review of the HIV medication Truvada for prevention, the more lives will be unnecessarily lost. This is particularly true for those at greatest risk: gay and bisexual men.
We urge the FDA to immediately begin its review for approval of Truvada for PrEP for gay and bisexual men.
Read the rest.
With PrEP, people who are not infected with HIV take a daily pill, usually used to treat the disease, to help prevent infection -- as part of a broad HIV
prevention approach that includes condoms and safer-sex counseling.
But the longer the FDA waits before beginning its review of the HIV medication Truvada for prevention, the more lives will be unnecessarily lost. This is particularly true for those at greatest risk: gay and bisexual men.
We urge the FDA to immediately begin its review for approval of Truvada for PrEP for gay and bisexual men.
Read the rest.
Should older men get vaccinated for HPV human papillomavirus?...
ReplyDelete